Vitality Therapeutics ApS: Financial statements 2023
CVR: 39913003
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Vitality Therapeutics ApS (CVR 39913003) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -329,086 and a net result of DKK -327,857 compared with DKK 300,062 the year before. Equity in the 2023 report amounted to DKK 126,219. The solvency ratio was 94.8%.
- Gross Profit
- DKK -329,086
- Profit/Loss
- DKK -327,857
- Equity
- DKK 126,219
- Total Assets
- DKK 133,138
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -329K | -328K | 126K | - |
| 2022 | - | 390K | 300K | 333K | - |
| 2021 | - | 0 | 0 | 33K | - |
| 2020 | - | 0 | 0 | -7K | - |
| 2019 | - | 0 | 0 | -7K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Vitality Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK 389,522, and the net result was DKK 300,062.
About Vitality Therapeutics ApS
Vitality Therapeutics ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company has been dissolved on 24 February 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Darius Moravcik Holding ApS and Darius Moravcik Holding IVS. In 2023, the company reported a gross profit of DKK -329,086 and a net result of DKK -327,857 compared with DKK 300,062 the year before. Equity in the 2023 report amounted to DKK 126,219.
